amiodarone has been researched along with Benign Neoplasms in 10 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using nationwide registers, we included all Danish patients with atrial fibrillation (AF) treated with amiodarone from 1996 to 2014." | 7.96 | Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study. ( D'Souza, M; Dalgaard, F; Hansen, ML; Hilmar Gislason, G; Pallisgaard, JL; Piccini, J; Rasmussen, PV; Ruwald, MH; Torp-Pedersen, C, 2020) |
| "Using nationwide registers, we included all Danish patients with atrial fibrillation (AF) treated with amiodarone from 1996 to 2014." | 3.96 | Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study. ( D'Souza, M; Dalgaard, F; Hansen, ML; Hilmar Gislason, G; Pallisgaard, JL; Piccini, J; Rasmussen, PV; Ruwald, MH; Torp-Pedersen, C, 2020) |
| "Those with antecedent cancer were excluded." | 1.39 | Amiodarone and the risk of cancer: a nationwide population-based study. ( Chen, TJ; Chou, KT; Hu, YW; Lee, YC; Lin, EY; Liu, CJ; Ou, SM; Su, VY; Tzeng, CH, 2013) |
| "Fourteen patients with Adr-resistant tumors were treated with Adr and AM." | 1.28 | In vitro and in vivo modulation of multi-drug resistance with amiodarone. ( de Vries, EG; Meijer, C; Mulder, NH; Mulder, PO; Nanninga, AG; Uges, DR; van der Graaf, WT; Vellenga, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rasmussen, PV | 1 |
| Dalgaard, F | 1 |
| Hilmar Gislason, G | 1 |
| Torp-Pedersen, C | 1 |
| Piccini, J | 1 |
| D'Souza, M | 1 |
| Ruwald, MH | 1 |
| Pallisgaard, JL | 1 |
| Hansen, ML | 1 |
| Su, VY | 2 |
| Hu, YW | 3 |
| Chou, KT | 1 |
| Ou, SM | 1 |
| Lee, YC | 1 |
| Lin, EY | 1 |
| Chen, TJ | 1 |
| Tzeng, CH | 1 |
| Liu, CJ | 3 |
| Bilir, C | 1 |
| Engin, H | 1 |
| Yi-Fong Su, V | 1 |
| Fares, WH | 1 |
| Lee, HC | 1 |
| Su, MY | 1 |
| Lo, HC | 1 |
| Wu, CC | 1 |
| Hu, JR | 1 |
| Lo, DM | 1 |
| Chao, TY | 1 |
| Tsai, HJ | 1 |
| Dai, MS | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| van der Graaf, WT | 2 |
| Buter, J | 1 |
| de Vries, EG | 2 |
| Willemse, PH | 1 |
| Sleijfer, DT | 1 |
| Mulder, NH | 2 |
| Uges, DR | 1 |
| Nanninga, AG | 1 |
| Meijer, C | 1 |
| Vellenga, E | 1 |
| Mulder, PO | 1 |
1 review available for amiodarone and Benign Neoplasms
| Article | Year |
|---|---|
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome".
Topics: Adult; Age Factors; Aged; Amiodarone; Animals; Anorexia Nervosa; Contrast Media; Diabetes Mellitus; | 1982 |
9 other studies available for amiodarone and Benign Neoplasms
| Article | Year |
|---|---|
Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Denmark; Fe | 2020 |
Amiodarone and the risk of cancer: a nationwide population-based study.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Female; Humans; | 2013 |
Reply to 'Amiodarone and the risk of cancer: a nationwide population-based study'.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Neoplasms; Population Surveillance | 2013 |
Amiodarone and the risk of cancer: a nationwide population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Neoplasms; Population Surveillance | 2013 |
Reply to subgroup analysis comment on amiodarone and the risk of cancer.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Neoplasms; Population Surveillance | 2013 |
Amiodarone and the risk of cancer: a nationwide population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Neoplasms; Population Surveillance | 2013 |
Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2.
Topics: Amiodarone; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Epit | 2015 |
High dose oral amiodarone added to doxorubicin and vindesine for overcoming multidrug resistance in solid tumors.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Antineoplastic Combined Chemotherapy Protocols; Doxor | 1994 |
In vitro and in vivo modulation of multi-drug resistance with amiodarone.
Topics: Adult; Amiodarone; Biological Transport; Carcinoma, Small Cell; Cell Line; Cell Survival; Colonic Ne | 1991 |